Jeffrey C Smith bought $111.0M of Kenvue (KVUE)
Executed Dec 11 2025, disclosed Dec 15 2025, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Dec 15 2025), the stock returned -1.3% (delay-adjusted); from the execution session (Dec 11 2025), -1.8%. Derived: entry at the session's open, exit at the close 20 sessions later.
Jeffrey C Smith (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Kenvue Inc. (KVUE). Across 1 priced purchase filing, the average 21-session return was -1.8% from execution and -1.3% from disclosure (delay-adjusted; derived). The largest single filing was $111.0M of KVUE (6,377,694 sh across 2 lots, as filed), executed Dec 11 2025.
Consumer Defensive · Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pa…
More Consumer Defensive filings→ Insider filings, newest first→ View the original filing at www.sec.gov→